research Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.


Delhi, Delhi, India
Pune, Kerala, India
Lucknow, Uttar Pradesh, India
Lucknow, Uttar Pradesh, India
Lucknow, Uttar Pradesh, India
Mumbai, Maharashtra, India